In(sci)te IP is a patent agency that provides a wide range of strategic services for companies operating in the pharmaceutical, biotech and life sciences industries.
About Us
In(sci)te IP’s team has experience in formulating real-world, practical IP strategies on a global scale. We are experienced in managing patent portfolios of all sizes and advising clients in mitigating patent-related risks associated with their patent assets. In(sci)te’s team offers a rare and desirable skill set borne out of a combination of corporate pharmaceutical IP law experience and a strong science background. This combination allows us to bring not just a scientific and corporate, but also a creative approach in understanding to help uncover a business’ true IP needs and thus allows us to present solutions that generate the maximum ROI.
In(sci)te IP’s team has experience in formulating real-world, practical IP strategies on a global scale. We are experienced in managing patent portfolios of all sizes and advising clients in mitigating patent-related risks associated with their patent assets. In(sci)te’s team offers a rare and desirable skill set borne out of a combination of corporate pharmaceutical IP law experience and a strong science background. This combination allows us to bring not just a scientific and corporate, but also a creative approach in understanding to help uncover a business’ true IP needs and thus allows us to present solutions that generate the maximum ROI.
Leadership
In(sci)te IP is led by Dr. Salim Mamajiwalla, a Canadian patent agent with extensive experience in assisting life science companies with their intellectual property needs. After having trained as a post-doctoral fellow at the world-renowned Cold Spring Harbor Laboratory, Dr. Mamajiwalla moved into the patent field and trained at premier Canadian law firms, assisting the firms' pharmaceutical, biotechnology and life science clients with their patent related intellectual property. Dr. Mamajiwalla was subsequently recruited by Biovail Corporation (now Valeant Pharmaceuticals International Inc.), Canada's largest publicly held pharmaceutical company, to head the company's IP department. Together with his corporate experience and his science background, Dr. Mamajiwalla understands the IP his clients strive to protect.
In(sci)te IP is led by Dr. Salim Mamajiwalla, a Canadian patent agent with extensive experience in assisting life science companies with their intellectual property needs. After having trained as a post-doctoral fellow at the world-renowned Cold Spring Harbor Laboratory, Dr. Mamajiwalla moved into the patent field and trained at premier Canadian law firms, assisting the firms' pharmaceutical, biotechnology and life science clients with their patent related intellectual property. Dr. Mamajiwalla was subsequently recruited by Biovail Corporation (now Valeant Pharmaceuticals International Inc.), Canada's largest publicly held pharmaceutical company, to head the company's IP department. Together with his corporate experience and his science background, Dr. Mamajiwalla understands the IP his clients strive to protect.
Services
-
Positioning
Aligning a company's business goals with its patent strategy
-
Research
Conducting
freedom-to-operate search and prior-art searches -
Strategy
Devising offensive and defensive patent protection strategies
-
Positioning
Aligning a company's business goals with its patent strategy
-
Research
Conducting
freedom-to-operate search and prior-art searches -
Strategy
Devising offensive and defensive patent protection strategies
-
Inspection
Reviewing all agreements to ensure sufficient IP protection provisions
-
Auditing
Auditing patent
portfolios -
Protection
Ensuring all relevant IP is captured prior to public disclosure
-
Drafiting & Prosecuting
Drafiting and prosecuting patent applications
Events & Articles
Co-Editor of book titled Intellectual Property in Molecular Medicine 01.11.15
Mamajiwalla, S. & Seide, R. (Eds.). (2015). Intellectual Property in Molecular Medicine. Cold Spring Harbor, N.Y. Cold Spring Harbor Laboratory Press.
Author of article in : ”Career Options for Biomedical Scientists”. 01.11.15
Mamajiwalla, S. (2015). Patent Law: At the Cutting Edge of Science, but Not at the Bench. In Janssen, K. & Sever, R. (Eds.). Career Options for Biomedical Scientists. (pp 121-134). Cold Spring Harbor, N.Y. Cold Spring Harbor Laboratory Press.
Co-Organizer of conference titled “Genes & Diagnostics: A Myriad of Issues in Biotech IP” 10.03.13
Download
Published a paper in the Life Sciences Law & Industry Report 24.08.12
Seide, R.K. and Mamajiwalla, S.M. (2012). Treating Prometheus: What Is The Prognosis for Process Claims? BNA: Life Sciences Law & Industry Report (6) 849.
Download
Events & Articles
Co-Editor of book titled Intellectual Property in Molecular Medicine 01.11.15
Mamajiwalla, S. & Seide, R. (Eds.). (2015). Intellectual Property in Molecular Medicine. Cold Spring Harbor, N.Y. Cold Spring Harbor Laboratory Press.Read More
Author of article in : ”Career Options for Biomedical Scientists”. 01.11.15
Mamajiwalla, S. (2015). Patent Law: At the Cutting Edge of Science, but Not at the Bench. In Janssen, K. & Sever, R. (Eds.). Career Options for Biomedical Scientists. (pp 121-134). Cold Spring Harbor, N.Y. Cold Spring Harbor Laboratory Press.Read More
Co-Organizer of conference titled “Genes & Diagnostics: A Myriad of Issues in Biotech IP” 10.03.13
Read More
Published a paper in the Life Sciences Law & Industry Report 24.08.12
Seide, R.K. and Mamajiwalla, S.M. (2012). Treating Prometheus: What Is The Prognosis for Process Claims? BNA: Life Sciences Law & Industry Report (6) 849.Read More